Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia

NCT00330382 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

325

Enrollment

NIH

Sponsor class

Conditions

Lip and Oral Cavity Cancer
Oral Leukoplakia
Oropharyngeal Cancer
Tongue Cancer

Interventions

DRUG: Bowman-Birk inhibitor concentrate
OTHER: placebo
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)